+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Wearable Injectors Market, by Type, by Technology, by Application, by End User

  • ID: 4656154
  • Report
  • November 2018
  • Region: Global
  • 200 pages
  • Blueweave Consulting & Research Pvt Ltd

FEATURED COMPANIES

  • Bühler Motor GmbH
  • CeQur SA
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • ScPharmaceuticals, Inc.
  • SteadyMed Ltd.
Wearable Injectors Market: Overview

The Global Wearable Injectors Market is expected to reach a value of US$ 13.0 Bn by 2024, owing to growing burden of geriatric population, increasing prevalence of chronic diseases, high demand for advanced drug delivery and increasing compliance for controlled drug delivery. The emerging economies offer ample growth opportunities for the global of wearable injectors market. However, alternative drug delivery methods hinder the growth of the global market. The market is projected to expand at a CAGR of 23.0% during the forecast period from 2018 to 2024 by value.

Accelerating pervasiveness of chronic diseases is driving the market growth

The demand for wearable injectors is increasing due to increasing prevalence of chronic and lifestyle associated diseases. The prevalence of chronic diseases, such as heart disease, cancer, stroke, and diabetes, is increasing due to the alteration in lifestyle and lack of access to preventive care. As reported by WHO in 2014, there were 422 million adults suffering from diabetes. Eastern Mediterranean region had the highest prevalence of diabetes (13.7%) in 2014, followed by South-East Asia (8.6%). According to Centre for Disease Control and Prevention (CDC), approximately 117 million people in 2012 in the U.S. had one or more chronic health conditions.

Wearable Injectors Market: Scope of the Report

The wearable injectors market can be segmented on the basis type, technology, application, end user and geography. Based on type, the global wearable injectors market is classified into body-worn patch injector, off-body worn belt injector, and bolus injector. Bolus injector market is expected to witness the fastest growth and is expected to grow at a CAGR of 42.36% during the forecast period. In end-user segment, the sale of wearable injectors in homecare segment is dominating.

North America is expected to lead the global wearable injectors market during the forecast period

North America led the global wearable injectors market; owing to rise in ageing population in the region the market has witness gain in terms of revenue in 2017. The North American wearable injectors market is expected to grow at a CAGR of 24.48% during the period 2018– 2024.

Global Wearable Injectors Market: Competitive Dynamics

The research study includes profiles of leading companies operating in the global Wearable Injectors market. Some of the key players profiled in the report include Johnson & Johnson, Medtronic plc, F. Hoffmann-La Roche Ltd, Unilife Corporation, etc.

The global Wearable Injectors market is segmented as below

Global Wearable Injectors Market, by Type
  • Body-worn patch injector
  • Off-body worn belt injector
  • Bolus injector
Global Wearable Injectors Market, by Technology
  • Electronical injector
  • Mechanical injector
  • Others
Global Wearable Injectors Market, by Application
  • Cancer
  • Infectious disease
  • Autoimmune disorder
  • Cardiovascular disease
  • Blood disorder
  • Others
Global Wearable Injectors Market, by End-user
  • Home care
  • Hospital
  • Lab & diagnostics
  • Others
Global Wearable Injectors Market, by Geography

North America
  • U.S.
  • Canada
  • Rest of North America
Europe
  • Germany
  • Italy
  • UK
  • France
  • Rest Of Europe
Asia Pacific (APAC)
  • India
  • China
  • Japan
  • Rest of APAC
  • Middle East & Africa (MEA)
Latin America
  • Brazil
Rest of Latin America


This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bühler Motor GmbH
  • CeQur SA
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • ScPharmaceuticals, Inc.
  • SteadyMed Ltd.
Chapter 1. Research Methodology
1.1 Market Definition
1.2 Research Scope
1.2.1 Global wearable injector market, by type
1.2.2 Global wearable injector market, by technology
1.2.3 Global wearable injector market, by application
1.2.4 Global wearable injector market, by end user
1.2.5 Global wearable injector market, by geography
1.3 Research Approach and Sources

Chapter 2. Executive Summary
2.1 Key Findings
2.2 Research Summary

Chapter 3. Market Outlook
3.1 Introduction
3.2 Global Wearable Injectors Market Opportunities
3.2.1 High usage of wearable injectors in emerging markets
3.3 Factors Driving the Growth of the Market and its Impact on Market Forecast
3.3.1 Ageing population
3.3.2 Accelerating pervasiveness of chronic diseases
3.3.3 Growing demand for advance drug delivery
3.3.4 Rise in pipeline for biologic drugs
3.3.5 Market analysis of drivers over forecast period
3.4 Restraning Factors hindering market growth
3.4.1 Alternative drug delivery methods
3.4.2 Disadvantage of wearable injector
3.4.3 Market challenges analysis on market forecast

Chapter 4. Global Wearable Injectors Market Size and Forecast (2012 – 2024)
4.1 Global Wearable Injectors Market, by Type
4.2 Global Wearable Injectors Market, by Technology
4.3 Global Wearable Injectors Market, by Application
4.4 Global Wearable Injectors Market, by End User
4.5 Global Wearable Injectors Market, by Region

Chapter 5. Global Wearable Injectors Market, by Type
5.1 Body-Worn Patch Injector Market
5.1.1 Global body-worn patch injector market, by region
5.2 Off-Body Worn Belt Injector Market
5.2.1 Global off-body worn belt injector market, by region
5.3 Bolus Injector Market
5.3.1 Global bolus injector market, by region

Chapter 6. Global Wearable Injectors Market, by Technology
6.1 Electronic Wearable Injector Market
6.1.1 Global electronic wearable injector market, by region
6.2 Mechanical Wearable Injector Market
6.2.1 Global mechanical wearable injectors market, by region

Chapter 7. Global Wearable Injectors Market, by Application
7.1 Wearable Injector Market for Cancer
7.1.1 Global wearable injector market for cancer, by region
7.2 Wearable Injector Market for Infectious Disease
7.2.1 Global wearable injector market for infectious disease, by region
7.3 Wearable Injector Market for Autoimmune Disorder
7.3.1 Global wearable injectors for autoimmune disorder, by region
7.4 Wearable Injectors Market for Cardiovascular Disease
7.4.1 Global wearable injector market for cardiovascular disese, by region
7.5 Wearable Injectors Market for Blood Disorder
7.6 Global wearable injector for blood disorder, by region

Chapter 8. Global Wearable Injectors Market, by End User
8.1 Wearable Injector Market in Homecare
8.2 Global wearable injector market in homecare, by region
8.3 Wearable Injector Market in Hospital
8.4 Global wearable injector market in hospital, by region
8.5 Wearable Injector Market in Lab & Diagnostics
8.6 Global wearable injector market in lab & diagnostics, by region

Chapter 9. Global Wearable Injectors Market, by Geography
9.1 North America Wearable Injector Market
9.1.1 North America wearable injector market, by type
9.1.2 North America wearable injector market, by technology
9.1.3 North America wearable injectors market, by application
9.1.4 North America wearable injector market, by end user
9.1.5 North America wearable injector market, by country
9.2 Latin America Wearable Injector Market
9.2.1 Latin America wearable injectors market, by type
9.2.2 Latin America wearable injector market, by technology
9.2.3 Latin America wearable injector market, by application
9.2.4 Latin America wearable injector market, by end user
9.2.5 Latin America wearable injector market, by country
9.3 Europe Wearable Injector Market
9.3.1 Europe wearable injector market, by type
9.3.2 Europe wearable injector market, by technology
9.3.3 Europe wearable injector market, by application
9.3.4 Europe wearable injector market, by end user
9.3.5 Europe wearable injector market, by country
9.4 APAC Wearable Injector Market
9.4.1 APAC wearable injector market, by type
9.4.2 APAC wearable injector market, by technology
9.4.3 APAC wearable injector market, by application
9.4.4 APAC wearable injector market, by end user
9.4.5 APAC wearable injector market, by country
9.5 MEA Wearable Injector Market
9.5.1 MEA wearable injector market, by type
9.5.2 MEA wearable injector market, by technology
9.5.3 MEA wearable injector market, by application
9.5.4 MEA wearable injector market, by end user

Chapter 10. Competitive Landscape
10.1 Porters Five Forces of Competitive Position Analysis
10.1.1 Bargaining power of buyers
10.1.2 Bargaining power of suppliers
10.1.3 Threat of new entrants
10.1.4 Intensity of rivalry
10.1.5 Threat of substitutes
10.2 Competitive Positioning of the Global Wearable Injectors Market, by Type
10.3 Competitive Benchmarking Of the Key Players in the Global Wearable Injectors Market, by Type
10.4 Market Share Analysis of the Global Wearable Injectors Market
10.5 Company Profiles
10.5.1 Becton, Dickinson and Company
10.5.1.1 Business overview
10.5.1.2 Product and service offerings
10.5.2 Medtronic plc
10.5.2.1 Business overview
10.5.2.2 Product and service offerings
10.5.3 Johnson & Johnson
10.5.3.1 Business overview
10.5.3.2 Product and service offerings
10.5.4 F. Hoffmann-La Roche Ltd.
10.5.4.1 Business overview
10.5.4.2 Product and service offerings
10.5.5 Unilife Corporation
10.5.5.1 Business overview
10.5.5.2 Product and service offerings
10.5.6 CeQur SA
10.5.6.1 Business overview
10.5.6.2 Product and service offerings
10.5.7 Sensile Medical AG
10.5.7.1 Business overview
10.5.7.2 Product and service offerings
10.5.8 Enable Injections
10.5.8.1 Business overview
10.5.8.2 Product and service offerings
10.5.9 ScPharmaceuticals, Inc.
10.5.9.1 Business overview
10.5.9.2 Product and service offerings
10.5.10 SteadyMed Ltd.
10.5.10.1 Business overview
10.5.10.2 Product and service offerings
10.5.11 Insulet Corporation
10.5.11.1 Business overview
10.5.11.2 Product and service offerings
10.5.12 Ypsomed Group
10.5.12.1 Business overview
10.5.12.2 Product and service offerings
10.5.13 West Pharmaceutical Services, Inc.
10.5.13.1 Business overview
10.5.13.2 Product and service offerings
10.5.14 Bühler Motor GmbH
10.5.14.1 Business overview
10.5.14.2 Product and service offerings
10.5.15 Canè S.p.A.
10.5.15.1 Business overview
10.5.15.2 Product and service offerings
10.6 Strategic Developments in the Global Wearable Injectors Market
10.7 List of Abbreviations 102
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Becton, Dickinson and Company
  • Medtronic plc
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Unilife Corporation
  • CeQur SA
  • Sensile Medical AG
  • Enable Injections
  • ScPharmaceuticals, Inc.
  • SteadyMed Ltd.
  • Insulet Corporation
  • Ypsomed Group
  • West Pharmaceutical Services, Inc.
  • Bühler Motor GmbH
  • Canè S.p.A.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll